Mutations in the von Hippel‐Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma
- 12 April 2002
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 80 (1) , 52-60
Abstract
Background and Objectives: Renal cell carcinomas (RCC) with abundant granular cytoplasm include oncocytomas, eosinophillic variants of chromophobe RCC, papillary RCC, collecting duct carcinoma, and some conventional (clear cell) RCC. Tumors with predominantly clear cell cytoplasm include typical chromophobe RCC and conventional (clear cell) RCC. The objective of this study was to determine if mutations in the VHL gene can serve as auxiliary diagnostic criteria in refining histology based subtyping of renal epithelial neoplasia.Methods: The study cohort of 67 cases included 24 conventional RCC, 14 chromophobe RCC, 14 papillary RCC, and 15 oncocytomas. Single strand conformational polymorphism (SSCP) was used as a screening procedure for mutations followed by automated sequencing to identify mutations.Results: Thirteen of the 14 mutations identified were novel, seven of which were in the coding region. In chromophobe RCC, mutations clustered in the 5′UTR/promoter region and have not been previously reported. Exon 3 appeared to favor conventional (clear cell) RCC and correlated with a more aggressive phenotype. Mutations were absent in the papillary and oncocytoma RCC subtypes.Conclusions: Exon 3 mutations permitted a morphological distinction between conventional (clear cell) RCC and chromophobe RCC with clear cells. Mutations in the VHL gene refine histologic diagnostic criteria in RCC serving as adjuncts to the present morphology based diagnosis of RCC. J. Surg. Oncol. 2002;80:52–60.Keywords
This publication has 30 references indexed in Scilit:
- Functions of the von Hippel–Lindau tumour suppressor proteinJournal of Internal Medicine, 1998
- Molecular genetic analysis of von Hippel–Lindau diseaseJournal of Internal Medicine, 1998
- Genotype–phenotype correlations in von hippel–lindau diseaseJournal of Internal Medicine, 1998
- Somatic mutations of von Hippel‐Lindau (VHL) tumor‐suppressor gene in european kidney cancersInternational Journal of Cancer, 1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinomaHuman Molecular Genetics, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- A PCR generated AccI RFLP in the 3′ untranslated region of the von Hippel — Lindau disease (VHL) tumour suppressor geneHuman Molecular Genetics, 1994
- Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated regionCell, 1993
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993